Numerous studies have implicated liver TNFα as a potential regulator of its development and TNFα levels are elevated in several models of NAFLD in rodents and in patients with NAFLD [76, 77]. This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.